SE447248B - Anvendning av 1,4-dihydro-2,6-dimetyl-4-(3-nitrofenyl)-pyridin-3-beta-metoxi-etylester-5-isopropylester for framstellning av cerebralt verksamma lekemedel - Google Patents

Anvendning av 1,4-dihydro-2,6-dimetyl-4-(3-nitrofenyl)-pyridin-3-beta-metoxi-etylester-5-isopropylester for framstellning av cerebralt verksamma lekemedel

Info

Publication number
SE447248B
SE447248B SE7903186A SE7903186A SE447248B SE 447248 B SE447248 B SE 447248B SE 7903186 A SE7903186 A SE 7903186A SE 7903186 A SE7903186 A SE 7903186A SE 447248 B SE447248 B SE 447248B
Authority
SE
Sweden
Prior art keywords
nitrophenyl
dimethyl
preparation
dihydro
cerebral
Prior art date
Application number
SE7903186A
Other languages
English (en)
Swedish (sv)
Other versions
SE7903186L (sv
Inventor
H Meyer
F Bossert
S Kazda
F Hoffmeister
W Vater
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6036687&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE447248(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SE7903186L publication Critical patent/SE7903186L/xx
Publication of SE447248B publication Critical patent/SE447248B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
SE7903186A 1978-04-11 1979-04-10 Anvendning av 1,4-dihydro-2,6-dimetyl-4-(3-nitrofenyl)-pyridin-3-beta-metoxi-etylester-5-isopropylester for framstellning av cerebralt verksamma lekemedel SE447248B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2815578A DE2815578C2 (de) 1978-04-11 1978-04-11 Neue pharmazeutische Verwendung von Nimodipin

Publications (2)

Publication Number Publication Date
SE7903186L SE7903186L (sv) 1979-10-12
SE447248B true SE447248B (sv) 1986-11-03

Family

ID=6036687

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7903186A SE447248B (sv) 1978-04-11 1979-04-10 Anvendning av 1,4-dihydro-2,6-dimetyl-4-(3-nitrofenyl)-pyridin-3-beta-metoxi-etylester-5-isopropylester for framstellning av cerebralt verksamma lekemedel

Country Status (27)

Country Link
US (1) US4406906A (fr)
EP (1) EP0004650B1 (fr)
JP (3) JPS54135776A (fr)
AT (1) AT383271B (fr)
AU (1) AU532623B2 (fr)
BE (1) BE875457A (fr)
CA (1) CA1140853A (fr)
CH (3) CH649468A5 (fr)
DE (2) DE2815578C2 (fr)
DK (1) DK150479A (fr)
ES (1) ES479474A1 (fr)
FI (1) FI791162A (fr)
FR (1) FR2422402A1 (fr)
GB (1) GB2018134A (fr)
GR (1) GR71463B (fr)
HK (1) HK59188A (fr)
IE (1) IE51651B1 (fr)
IL (1) IL57030A (fr)
IT (1) IT1062201B (fr)
LU (2) LU88273I2 (fr)
NL (2) NL7902778A (fr)
NO (1) NO791009L (fr)
NZ (1) NZ190133A (fr)
PH (1) PH15574A (fr)
SE (1) SE447248B (fr)
SG (1) SG18688G (fr)
ZA (1) ZA791728B (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3270785D1 (en) * 1981-10-29 1986-05-28 Bayer Ag Process for preparing solid fast-releasing drug formulations of dihydropyridines
DE3142853A1 (de) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen mit nifedipin und verfahren zu ihrer herstellung
JPS58172312A (ja) * 1982-04-02 1983-10-11 Toa Eiyou Kagaku Kogyo Kk ニフエジピン外用剤
JPS58177916A (ja) * 1982-04-13 1983-10-18 Kowa Co 外用剤
DE3307422A1 (de) * 1983-03-03 1984-09-06 Bayer Ag, 5090 Leverkusen Fluessigzubereitungen von dihydropyridinen, ein verfahren zu ihrer herstellung, sowie ihre verwendung bei der bekaempfung von erkrankungen
US4690935A (en) * 1983-03-31 1987-09-01 Wayne State University Inhibition of tumor growth and metastasis with calcium channel blocker compounds
DE3316510A1 (de) * 1983-05-06 1984-11-08 Bayer Ag Parenterale formulierung von nimodipin, ein verfahren zu ihrer herstellung sowie ihre verwendung bei der bekaempfung von erkrankungen
DE3339236A1 (de) * 1983-10-28 1985-05-09 Bayer Ag Arzneimittelzubereitung
DE4342196A1 (de) * 1993-12-10 1995-06-14 Bayer Ag Neue 4-Phenyl-substituierte 1,4-Dihydropyridine
FR2568773B1 (fr) * 1984-08-10 1989-03-03 Sandoz Lab Nouvelles compositions pharmaceutiques administrables par voie nasale
EP0175671A1 (fr) * 1984-08-23 1986-03-26 Kuhlemann & Co. Préparation pharmaceutique et procédé pour l'administration de cette préparation pharmaceutique
DE3438830A1 (de) * 1984-10-23 1986-04-30 Rentschler Arzneimittel Nifedipin enthaltende darreichungsform und verfahren zu ihrer herstellung
DE3544692A1 (de) * 1985-12-18 1987-06-19 Bayer Ag Dihydropyridinspray, verfahren zu seiner herstellung und seine pharmazeutische verwendung
US4758669A (en) * 1986-05-05 1988-07-19 Radiation Oncology Center Research And Development Corporation 4-(nitrone aryl) dihydropyridines
US5401759A (en) * 1989-11-16 1995-03-28 Miles Inc. Nimodipine enhanced growth and vascularization of neural grafts
RU1804845C (ru) * 1991-02-15 1993-03-30 Институт Органического Синтеза Латвийской Ан Ноотропное вещество
JP2793410B2 (ja) * 1991-04-22 1998-09-03 インターナショナル・ビジネス・マシーンズ・コーポレイション ウェブ駆動装置及びテープ駆動装置
US5438144A (en) * 1991-07-30 1995-08-01 Troponwerke Gmbh & Co. Kg Use of 1,4-dihydropyridines in diabetes
DE4130173A1 (de) * 1991-09-11 1993-03-18 Bayer Ag Pharmazeutische zubereitungen mit einer speziellen kristallmodifikation des 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridindicarbonsaeure-isopropyl-(2-methoxyethyl)-esters
DE4133257A1 (de) * 1991-10-08 1993-04-15 Bayer Ag N-methyl-nimodipin, verfahren zu seiner herstellung und seine verwendung als zerebraltherapeutikum
IT1255792B (it) * 1992-08-05 1995-11-16 Bayer Italia Spa Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda
US6001857A (en) * 1992-10-30 1999-12-14 Bayer Aktiengesellschaft Heterocyclyl substituted dihydropyridines
ATE146788T1 (de) * 1992-10-30 1997-01-15 Bayer Ag 4-heterocyclophenyl substituierte dihydropyridine
DE4236707A1 (de) * 1992-10-30 1994-05-05 Bayer Ag 4-Heterocyclyl substituierte Dihydropyridine
SE9203857D0 (sv) * 1992-12-22 1992-12-22 Astra Ab Use of an enantiomeric dihydropyridine
EP0657432B1 (fr) 1993-12-10 2003-03-12 Bayer Ag 1,4-Dihydropyridines substitués par un groupement phényle avec une activité cérébrale
DE4342193A1 (de) * 1993-12-10 1995-06-14 Bayer Ag Arylsubstituierte Alkoxycarbonyl-1,4-dihydropyridin-5-carbonsäureester
EE03192B1 (et) * 1993-12-10 1999-06-15 Bayer Aktiengesellschaft Isopropüül-(2-metoksüetüül)-4-(2-kloro-3-tsüanofenüül)-1,4-dihüdro-2,6-dimetüülpüri diin-3,5-dikarboksülaat, selle enantiomeerid ja vaheühend, meetodid nimetatud ühendite valmistamiseks ja kasutamine
DE4430094A1 (de) * 1994-08-25 1996-02-29 Bayer Ag Verwendung von 3,5-Dicarbonsäureester-1,4-Dihydropyridinen als Arzneimittel
US6078481A (en) * 1998-06-08 2000-06-20 Imation Corp. Tape storage cartridge having two-level tape path
AR027152A1 (es) * 2000-12-29 2003-03-12 Osmotica Argentina S A Composicion farmaceutica para el tratamiento de la enfermedad cerebrovascular cognitiva.
DE10142417A1 (de) * 2001-08-31 2003-03-20 Molecular And Clinical Drug Re Arzneimittel
CN1649614A (zh) 2002-02-22 2005-08-03 新河药品股份有限公司 活性剂传递系统和保护及施用活性剂的方法
US20070117851A1 (en) * 2005-10-14 2007-05-24 Transform Pharmaceuticals, Inc. Liquid pharmaceutical compositions of nimodipine
WO2009032286A2 (fr) 2007-09-06 2009-03-12 Nektar Therapeutics Al, Corporation Conjugués oligomère - bloqueur de canaux calciques
US9737478B2 (en) * 2009-09-28 2017-08-22 National Institutes of Health (NIH), U.S. Dept. of Health and Human Services (DHHS), The United States of America NIH Division of Extramural Inventions and Technology Resources (DEITR) Treatment of malaria

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2117573C3 (de) * 1971-04-10 1978-07-27 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von unsymmetrischen l,4-Dihydropyridin-3,5dicarbonsäureestern, sowie ihre Verwendung als Arzneimittel
GB1430961A (en) * 1972-01-22 1976-04-07 Yamanouchi Pharma Co Ltd 1-substituted-1,4-dihyddrypyridine derivatives
GB1455502A (en) * 1973-02-20 1976-11-10 Yamanouchi Pharma Co Ltd 1,4-dihydropyridine derivatives

Also Published As

Publication number Publication date
DK150479A (da) 1979-10-12
NL930034I2 (nl) 1993-10-01
HK59188A (en) 1988-08-12
GB2018134A (en) 1979-10-17
JPS54135776A (en) 1979-10-22
DE2967573D1 (en) 1986-03-13
AU4583579A (en) 1979-10-18
LU81133A1 (de) 1979-11-07
NZ190133A (en) 1985-02-28
IE51651B1 (en) 1987-02-04
FR2422402B1 (fr) 1982-07-02
AT383271B (de) 1987-06-10
BE875457A (fr) 1979-10-10
LU88273I2 (fr) 1994-02-03
PH15574A (en) 1983-02-17
ES479474A1 (es) 1979-12-16
IL57030A (en) 1982-09-30
GR71463B (fr) 1983-05-30
DE2815578C2 (de) 1986-01-16
IE790756L (en) 1979-10-11
NO791009L (no) 1979-10-12
US4406906A (en) 1983-09-27
CH649468A5 (de) 1985-05-31
JPS591412A (ja) 1984-01-06
NL7902778A (nl) 1979-10-15
DE2815578A1 (de) 1979-10-18
CH649921A5 (de) 1985-06-28
IL57030A0 (en) 1979-07-25
AU532623B2 (en) 1983-10-06
NL930034I1 (nl) 1993-08-02
JPS5730089B2 (fr) 1982-06-26
EP0004650A1 (fr) 1979-10-17
EP0004650B1 (fr) 1986-01-29
IT7921692A0 (it) 1979-04-09
IT1062201B (it) 1983-07-29
CH640734A5 (de) 1984-01-31
JPS58219117A (ja) 1983-12-20
FI791162A (fi) 1979-10-12
ATA262179A (de) 1986-11-15
CA1140853A (fr) 1983-02-08
SE7903186L (sv) 1979-10-12
ZA791728B (en) 1980-05-28
SG18688G (en) 1989-07-07
FR2422402A1 (fr) 1979-11-09

Similar Documents

Publication Publication Date Title
SE447248B (sv) Anvendning av 1,4-dihydro-2,6-dimetyl-4-(3-nitrofenyl)-pyridin-3-beta-metoxi-etylester-5-isopropylester for framstellning av cerebralt verksamma lekemedel
ES2822350T3 (es) Formulaciones parenterales mejoradas de agentes farmacéuticos lipófilos y procedimientos de preparación y uso de las mismas
US20080300253A1 (en) Treatment of inflammatory disorders with praziquantel
HU199302B (en) Process for producing synergic pharmaceutical compositions having hypotensive activity
EP0572922A1 (fr) Combinaisons synergiques comprenant de l'acide lipoique et des vitamines dans des médicaments
CA2184695A1 (fr) Augmentation des concentrations foetales d'hemoglobine a l'aide d'esters carboxyliques
CH638535A5 (de) Metronidazolphosphorsaeure(salze), sowie diese enthaltende arzneimittel.
JPH07509456A (ja) ２型糖尿病および肥満の治療および予防のための１，３−ジシクロプロピメチル−８−アミノ−キサンチンの使用
NL193066C (nl) Methyl,isopropyl-4-(2,1,3-benzoxadiazool-4-yl)-2,6-dimethyl-1,4-dihydro pyridine-3,5-dicarboxylaat en farmaceutisch preparaat dat deze verbinding bevat.
JPH09510979A (ja) 内皮性機能障害の予防および治療用医薬製剤および医薬品
US4582840A (en) 1,4-dihydro-2,6-dimethyl-4-nitrophenyl-3,5-pyridinedicarboxylic acid esters useful for treating renal insufficiency
RU2367442C2 (ru) Способ нормализации мочеиспускания при нарушении функции почек
TW200812989A (en) Novel heterocyclic diphenyl ethers
JPH07507288A (ja) デスフェリオキサミン−ｂ塩及び経口的に有効な鉄キレート剤としてのそれらの使用
WO1999025365A1 (fr) Utilisation des ketolides pour prevenir les complications thrombotiques arterielles liees a l'atherosclerose
CN101448550A (zh) 嗜球果伞素用于铁代谢障碍治疗的用途
CN112755018A (zh) 漆黄素在制备防治尿酸性肾病的药物中的用途
FR2544614A1 (fr) Nouvelle association medicamenteuse pour le traitement de l'hypertension
EP0908177B1 (fr) Procédé pour former des compositions pharmaceutiques de bromazépam sous forme de granules ou pilules sphériques à action controlée et soutenue et compositions pharmaceutiques obtenues par ce procédé
CA1331568C (fr) Composition pharmaceutique contenant du dihydropyridine-dianhydrohexitol et un derive nitre
DE2416608A1 (de) Neue 5-aryl-pyrido-(b-6,7)-1,4-diazepine mit einem weiteren annellierten heterocyklus
US3317385A (en) Method of treatment of depression in mammals
JPH0228113A (ja) 高尿酸血症改善・治療剤
JPH0544925B2 (fr)
JPH02286617A (ja) 血管新生阻害剤

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7903186-0

Effective date: 19930307

Format of ref document f/p: F